
| CMEonHIV exclusive ! |
|
 |
Antiretroviral Therapy in Naīve Patients
The QUAD and Time Studies tested various regimens in ARV naīve patients. The QUAD Study tested a 4 drug regimen against a 3 drug regimen: TZV+SQV/R vs CBV+SQV/R. The Time Study looked at (TZV/EFV 48 weeks) vs (TZV/EFV 24 weeks followed by TZV 24 weeks) vs TZV 48 weeks. New data from these studies will be discussed here, as well as data on the time...
|
 |
HIV/HCV Co-infection
Although the EUROSIDA Study showed no role of HCV in accelerating the progression of AIDS, there was a rise observed in liver related deaths in HIV/HCV co-infected patients. Clinical data on peg alpha 2a plus Ribavirin (PRESCO Study), and peg alpha 2b plus Ribavirin (Santos et al) in treatment of HIV/HCV co-infected patients will be discussed here, as well as new...
|
 |
Management of ART-Experienced and Salvage Patients
In this presentation Dr Fraser will discuss the evolution of HIV drug resistance in relation to replicative capacity and viremia based on a clinical cohort study (Deeks et al); and give a review of cohort studies on...
|
|
|
 |
|
PubMed: Latest Scientific Publication (NCBI: db=PubMed; RSS Feed) |
|
 |

| Search our Database |
 |
| |
Find the information that you are looking for in over +3000 resources. |
| |
|
|

|